425: Clearwater Analytics and Enfusion Announce Preliminary Results of Merger Consideration Election

Clearwater Analytics and Enfusion have announced the preliminary results of the election by Enfusion shareholders regarding the form of merger consideration they wish to receive in connection with Clearwater's acquisition of Enfusion.

Summary

• Clearwater Analytics and Enfusion announced preliminary results of the election by Enfusion shareholders regarding the form of merger consideration in Clearwater's acquisition of Enfusion.
• The deadline for the election was April 16, 2025, at 5:00 p.m. Eastern Time.
• The parties expect the transaction to close on April 21, 2025, pending Enfusion shareholder approval and customary closing conditions.
• Enfusion shareholders could elect to receive per share mixed consideration, per share stock consideration, or per share cash consideration.
• The value paid per share of Enfusion Class A common stock will be equalized such that the value of the Merger Consideration will be substantially the same, regardless of which form of Merger Consideration is elected.
• Assuming the transaction closes on April 21, 2025, the Final Parent Stock Price, based on the volume-weighted average price per share of Clearwater Class A common stock for the ten-trading day period ending on (and including) April 16, 2025, is $23.2440.
• The total number of Eligible Shares is expected to be 129,995,464.
• Based on these figures, the Per Share Parent Stock Amount would be 0.2159, the Aggregate Consideration would be $1,412,840,049.03, the Aggregate Consideration Per Share would be $10.87, the Per Share Cash Consideration would be $10.87, and the Exchange Ratio would be 0.4676.
• Approximately 45.5% of Enfusion shareholders elected to receive the Per Share Mixed Consideration, 6.1% elected the Per Share Stock Consideration, and 40.9% elected the Per Share Cash Consideration.
• About 7.6% did not make a valid election and will receive the Per Share Stock Consideration.
• The Per Share Cash Consideration option is oversubscribed and will be prorated.
• The companies expect that the Corporate Mergers will qualify as a reorganization under Section 368(a) of the Internal Revenue Code of 1986.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the merger is progressing as expected, but there are risks associated with integration and potential proration of cash consideration.

Positives

• The acquisition is progressing as planned, with an anticipated closing date.
• The companies expect the merger to qualify as a reorganization under Section 368(a) of the Internal Revenue Code.

Negatives

• The cash consideration option is oversubscribed, which means some shareholders who elected cash may receive a prorated amount.
• The final results of the election are preliminary and subject to change.

Risks

• The ability to successfully close the acquisition is subject to shareholder approval and customary closing conditions.
• Clearwater's ability to successfully integrate Enfusion's operations and technology is a risk.
• Retaining and incentivizing Enfusion's employees after the acquisition is a potential challenge.
• There is a risk of not retaining Enfusion's clients.
• Repaying debt incurred for the acquisition and meeting financial covenants could pose risks.
• Cost savings, synergies, and growth from the acquisition may not be fully realized or may take longer than expected.

Future Outlook

The transaction is expected to close on April 21, 2025, subject to shareholder approval and customary closing conditions. The companies anticipate that the merger will qualify as a reorganization under Section 368(a) of the Internal Revenue Code.

Industry Context

This announcement reflects ongoing consolidation trends within the financial technology sector, where companies are seeking to expand their capabilities and market reach through strategic acquisitions. Clearwater's acquisition of Enfusion aims to combine their respective strengths in investment management software and services.

Comparison to Industry Standards

• Comparable transactions in the financial technology sector include Vista Equity Partners' acquisition of Misys and ION Trading's acquisition of Fidessa.
• These deals often involve significant premiums and focus on achieving synergies through integrated product offerings and expanded customer bases.
• The Clearwater-Enfusion deal aligns with this trend, as it seeks to create a more comprehensive platform for investment management.

Stakeholder Impact

• Enfusion shareholders will receive consideration in the form of cash and/or Clearwater stock.
• Clearwater shareholders may see changes in the value of their stock due to the acquisition.
• Employees of both companies may experience changes as a result of the integration.
• Clients of both companies may benefit from a more comprehensive platform.

Next Steps

• Enfusion shareholders need to approve the transaction.
• The companies need to satisfy or waive other customary closing conditions.
• Final merger consideration and allocation will be computed after the final results of the election process are determined.

Key Dates

Keywords

Merger Consideration, Enfusion, Clearwater Analytics, Acquisition, Shareholders, Election, Transaction